Business Context and Reporting Period
This Form 8-K is a current report filed by cbdMD, Inc. on January 14, 2020. The registrant is an emerging growth company incorporated in North Carolina. The report primarily addresses the closing of a previously announced firm commitment underwriting public offering.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notification of a corporate event rather than a financial performance report.
Material Changes
- Capital Raise Completion: On January 14, 2020, the company announced the closing of its firm commitment underwriting public offering.
- Securities Registered: The company has Common Stock (YCBD) and 8.0% Series A Cumulative Convertible Preferred Stock (YCBD PR A) registered on the NYSE American.
Guidance, Outlook, and Risks
The filing does not contain specific management guidance, future outlook, or detailed risk factors. It references a press release (Exhibit 99.1) for further details regarding the offering but does not include the text of that release within this summary.
Investor Verification Checklist
- Verify the total proceeds raised and the number of shares issued in the closed public offering by reviewing the referenced press release (Exhibit 99.1).
- Confirm the use of proceeds from the offering as disclosed in the offering documents.
- Review the terms of the 8.0% Series A Cumulative Convertible Preferred Stock to understand conversion rights and dividend obligations.
- Check subsequent filings for the impact of this capital raise on the company's cash position and debt structure.